2145-0277 Screening compound: 2-{[5-bromo-3-cyano-4-(methoxymethyl)-6-methylpyridin-2-yl]oxy}-N'-[(E)-[1-(4-methylphenyl)-2,5-diphenyl-1H-pyrrol-3-yl]methylidene]acetohydrazide

2145-0277 Screening compound: 2-{[5-bromo-3-cyano-4-(methoxymethyl)-6-methylpyridin-2-yl]oxy}-N'-[(E)-[1-(4-methylphenyl)-2,5-diphenyl-1H-pyrrol-3-yl]methylidene]acetohydrazide
2145-0277 Screening compound: 2-{[5-bromo-3-cyano-4-(methoxymethyl)-6-methylpyridin-2-yl]oxy}-N'-[(E)-[1-(4-methylphenyl)-2,5-diphenyl-1H-pyrrol-3-yl]methylidene]acetohydrazide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2145-0277
2-{[5-bromo-3-cyano-4-(methoxymethyl)-6-methylpyridin-2-yl]oxy}-N'-[(E)-[1-(4-methylphenyl)-2,5-diphenyl-1H-pyrrol-3-yl]methylidene]acetohydrazide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2145-0277

Molecular Formula

C35H30BrN5O3 (C35 H30 BrN5 O3)

Compound Name

2-{[5-bromo-3-cyano-4-(methoxymethyl)-6-methylpyridin-2-yl]oxy}-N'-[(E)-[1-(4-methylphenyl)-2,5-diphenyl-1H-pyrrol-3-yl]methylidene]acetohydrazide

IUPAC name

2-{[5-bromo-3-cyano-4-(methoxymethyl)-6-methylpyridin-2-yl]oxy}-N'-[(E)-[1-(4-methylphenyl)-25-diphenyl-1H-pyrrol-3-yl]methylidene]acetohydrazide

SMILES

Cc(cc1)ccc1-n1c(-c2ccccc2)c(/C=N/NC(COc(nc(C)c(Br)c2COC)c2C#N)=O)cc1-c1ccccc1

InChI

InChI=1S/C35H30BrN5O3/c1-23-14-16-28(17-15-23)41-31(25-10-6-4-7-11-25)18-27(34(41)26-12-8-5-9-13-26)20-38-40-32(42)22-44-35-29(19-37)30(21-43-3)33(36)24(2)39-35/h4-18,20H,21-22H2,1-3H3,(H,40,42)

InChI Key

NOCFDZDUOPUHFG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01133604

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

648.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

7.544

Distribution Coefficient, logD

7.544

Water Solubility, LogSw

-5.66

Polar Surface Area

78.451

Acid Dissociation Constant (pKa)

11.49

Base Dissociation Constant (pKb)

3.06

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.30

2145-0277 in Drug Discovery

Included in Screening Libraries

Akt-Targeted Library (14764 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with 2145-0277 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2145-0277?
Check Price and Availability of 2145-0277, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2145-0277 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2145-0277
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2145-0277
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2145-0277 available by request